TrialOrphanet journal of rare diseases2021

A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1A.

Shahram Attarian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.